Dr. Reddy’s Laboratories faces ₹184 crore penalty over ‘unpaid GST on excess refund settlement’ 


Dr. Reddy’s Laboratories has received an order directing the company to pay more than ₹184 crore penalty under the CGST Act 2017. The authority has passed the order on the contention that the company has received excess refund and not paid Goods and Services Tax (GST) on settlement amount, the drugmaker said in a filing on the order received from the Additional Commissioner of Central Tax, Ranga Reddy GST Commissionerate, Hyderabad.

The January 28 order, which the company said it received on February 1, levies a penalty of ₹1,84,35,58,762. “Based on our evaluation, there is no material impact on the financials, operations or other activities of the company,” Dr. Reddy’s said.

It will evaluate filing necessary appeal with the appellate authority, it said without sharing details of the settlement amount.



Source link

  • Related Posts

    Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI

    Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for commercialisation of chronic obstructive pulmonary disease drug Tiotropium Dry Powder Inhaler, 18 mcg/capsule, in the Chinese…

    Continue reading
    India to export 150 locomotives to Africa worth over ₹3,000 crore

    “These locomotives are fitted with Distributed Power Wireless Control System, or DPWCS, for synchronised operations and superior freight handling,” a Railways Ministry spokesperson said. Photo: https://www.wabteccorp.com/ India will supply 150…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *